Open access · CC-BY
via OpenAlex
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
Yousef Khazaei Monfared, Pedram Heidari, Samuel Jacob Klempner, Umar Mahmood, Aparna R. Parikh, Theodore Sunki Hong, Matthew R. Strickland, Shadi Abdar Esfahani
Pharmaceutics · 2023 · ▲ 57 citations
Abstract
DNA is an organic molecule that is highly vulnerable to chemical alterations and breaks caused by both internal and external factors. Cells possess complex and advanced mechanisms, including DNA repair, damage tolerance, cell cycle checkpoints, and cell death pathways, which together minimize the potentially harmful effects of DNA damage. However, in cancer cells, the normal DNA damage tolerance and response processes are disrupted or deregulated. This results in increased mutagenesis and genomic instability within the cancer cells, a known driver of cancer progression and therapeutic resistance. On the other hand, the inherent instability of the genome in rapidly dividing cancer cells can be exploited as a tool to kill by imposing DNA damage with radiopharmaceuticals. As the field of targeted radiopharmaceutical therapy (RPT) is rapidly growing in oncology, it is crucial to have a deep understanding of the impact of systemic radiation delivery by radiopharmaceuticals on the DNA of tumors and healthy tissues. The distribution and activation of DNA damage and repair pathways caused by RPT can be different based on the characteristics of the radioisotope and molecular target. Here we provide a comprehensive discussion of the biological effects of RPTs, with the main focus on the role of varying radioisotopes in inducing direct and indirect DNA damage and activating DNA repair pathways.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/pharmaceutics15122761
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Monfared, Y.K., Heidari, P., Klempner, S.J., Mahmood, U., Parikh, A.R., Hong, T.S., Strickland, M.R., & Esfahani, S.A. (2023). DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair. <em>Pharmaceutics</em>. https://doi.org/10.3390/pharmaceutics15122761
Vancouver
Monfared YK, Heidari P, Klempner SJ, Mahmood U, Parikh AR, Hong TS, et al. DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair. Pharmaceutics. 2023. doi:10.3390/pharmaceutics15122761.
BibTeX
@article{yousef2023DNADam,
title = {DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair},
author = {Yousef Khazaei Monfared and Pedram Heidari and Samuel Jacob Klempner and Umar Mahmood and Aparna R. Parikh and Theodore Sunki Hong and Matthew R. Strickland and Shadi Abdar Esfahani},
journal = {Pharmaceutics},
year = {2023},
doi = {10.3390/pharmaceutics15122761},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Student Research 2022
Open access · CC-BY
Telomeres and Telomerase in Cancer: Overview and Therapeutic Potential
Journal of Molecular Cell Biology 2014
Open access · CC-BY
CHK2 kinase in the DNA damage response and beyond
Cancers 2020
Open access · CC-BY
Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer
Metabolites 2023
Open access · CC-BY
Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
Arteriosclerosis Thrombosis and Vascular Biology 2020
Open access · OA
DNA Damage Response
Cardiovascular Research 2006
Citation only